Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Boehringer Ingelheim
Harvard Business School
McKesson
Johnson and Johnson

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

Mepivacaine hydrochloride - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic sources for mepivacaine hydrochloride and what is the scope of patent protection?

Mepivacaine hydrochloride is the generic ingredient in seven branded drugs marketed by Solvay, Eastman Kodak, Hospira, Septodont Inc, Belmora Llc, Hospira Inc, Intl Medication Sys, Watson Labs, Dentsply Pharm, Fresenius Kabi Usa, and Deproco, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for mepivacaine hydrochloride. Twelve suppliers are listed for this compound.

Recent Clinical Trials for mepivacaine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Massachusetts Institute of TechnologyPhase 1
Brigham and Women's HospitalPhase 1
Thomas Jefferson UniversityN/A

See all mepivacaine hydrochloride clinical trials

Pharmacology for mepivacaine hydrochloride
Drug ClassAmide Local Anesthetic
Physiological EffectLocal Anesthesia
Medical Subject Heading (MeSH) Categories for mepivacaine hydrochloride
Synonyms for mepivacaine hydrochloride
(+-)-1-Methyl-2',6'-pipecoloxylidide monohydrochloride
(+/-)-Mepivacaine hydrochloride, >=98% (HPLC)
(1-Methyl-DL-piperidine-2-carboxylic acid)-2,6-dimethylanilide hydrochloride
(1-methyl-dl-piperidine-2-carboxylicacid)-2,6-dimethylanilidehydrochloride
1-methyl-2 inverted exclamation mark ,6 inverted exclamation mark -pipecoloxylididehydrochloride
1-Methyl-2 inverted exclamation marka,6 inverted exclamation marka-pipecoloxylidine hydrochloride
1-Methyl-2',6'-pipecoloxylidide hydrochloride
1-Methyl-2',6'-pipecoloxylidide monohydrochloride
1-Methyl-2',6'-pipecoloxylidine hydrochloride
16452-56-5
1722-62-9
2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-methyl-, monohydrochloride
2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-methyl-, monohydrochloride, (+-)-
2',6'-Pipecoloxylidide, 1-methyl -, monohydrochloride
38423-99-3
6 inverted exclamation mark -pipecoloxylidide,1-methyl-2monohydrochloride
722M629
96-88-8 (Parent)
A811391
AB0012058
AC-2102
AC1L24K2
ACT02686
AKOS015889311
AN-14290
ANW-46921
API0003297
Arestocaine HCL
Arestocaine hydrochloride
AX8032267
BC220537
BCP21546
BG0250
BR-61115
C-17796
Carbocain
Carbocaina
Carbocaine (TN)
Carbocaine hydrochloride
Carbocaine monohydrochloride
carbocainehydrochloride
CAS-1722-62-9
CC-30208
CCG-101083
CCG-39081
CHEBI:6760
CHEMBL1200440
Chlorocain
CPD000058904
CS-2729
CTK8B4971
D00738
dl-1-methyl-2 inverted exclamation mark ,6 inverted exclamation mark -pipecoloxylididehydrochloride
dl-mepivacainehydrochloride
DSSTox_CID_11566
DSSTox_GSID_31566
DSSTox_RID_78885
DTXSID4031566
EINECS 217-023-9
FT-0080089
FT-0601566
HMS1922D17
HY-B0517A
I01-1865
Isocaine HCL
ISOCAINE HYDROCHLORIDE
KS-00001F7F
KS-1271
LS-2120
M2560
MCULE-4459584385
Meaverin
Mepicaton
Mepident
mepivacain hydrochloride
Mepivacaine (hydrochloride)
Mepivacaine chlorhydrate
Mepivacaine HCL
Mepivacaine hydrochloride (JP17/USP)
Mepivacaine hydrochloride [USAN:JAN]
Mepivacaine hydrochloride [USP:JAN]
Mepivacaine hydrochloride, 98.0-102.0%, meets USP testing specifications
Mepivacaine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Mepivacaine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Mepivacaine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Mepivacaine Monohydrochloride
Mepivacaine(hydrochloride)
MepivacaineHCL//Mepivacaine
Mepivastesin
Mepivicaine hydrochloride
MEPIVICAINE HYDROCHLORIDE (MEPIVICAINE (96-88-8))
MFCD00144738
MLS000028662
MLS001074068
MLS001424226
MolPort-003-666-532
N-(2,6-Dimethylphenyl)-1-methyl-2-piperidinecarboxamide hydrochloride
n-(2,6-dimethylphenyl)-1-methyl-2-piperidinecarboxamidmonohydrochloride
N-(2,6-dimethylphenyl)-1-methyl-piperidine-2-carboxamide hydrochloride
N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide hydrochloride
N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide hydrochloride (1:1)
N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide;hydrochloride
N-(2,6-dimethylphenyl)(1-methyl(2-piperidyl))carboxamide, chloride
NC00333
NCGC00095108-01
NCGC00095108-02
NCGC00095108-03
NSC-758674
NSC758674
Opera_ID_1165
Optocain
Pharmakon1600-01504148
Polocaine (TN)
Polocaine-Mpf
Q-201354
RETIMRUQNCDCQB-UHFFFAOYSA-N
S-6505
s3155
Sabol
SAM001246875
SBB057000
SC-13935
Scandinibsa
Scandonest
Scandonest Plain
Scandonest plain (TN)
SCHEMBL34245
SMR000058904
SPECTRUM1504148
SR-01000000263
SR-01000000263-4
ST2419639
ST50993897
SW197713-3
TC-135666
Tox21_111424

US Patents and Regulatory Information for mepivacaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc MEPIVACAINE HYDROCHLORIDE mepivacaine hydrochloride INJECTABLE;INJECTION 040806-001 Apr 28, 2008 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs MEPIVACAINE HYDROCHLORIDE mepivacaine hydrochloride INJECTABLE;INJECTION 088769-001 Nov 20, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Septodont Inc ISOCAINE HYDROCHLORIDE mepivacaine hydrochloride INJECTABLE;INJECTION 080925-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Eastman Kodak CARBOCAINE mepivacaine hydrochloride INJECTABLE;INJECTION 012125-003 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Hospira CARBOCAINE mepivacaine hydrochloride INJECTABLE;INJECTION 012250-005 Approved Prior to Jan 1, 1982 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Moodys
McKinsey
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.